(Q52578529)

3 May 2018

title

Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice. (English)

1 reference

3 May 2018

0 references

X M Li

1

1 reference

3 May 2018

F Lévi

series ordinal

2

1 reference

3 May 2018

publication date

1 April 2007

1 reference

3 May 2018

Journal of Biological Rhythms

published in

1 reference

3 May 2018

volume

22

1 reference

3 May 2018

issue

2

1 reference

3 May 2018

page(s)

159-166

1 reference

3 May 2018

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Circadian variation in the expression of cell-cycle proteins in human oral epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Phase II study of gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Advanced breast cancer: a phase II trial with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Gemcitabine-induced systemic capillary leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Circadian rhythms and the pharmacology of affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Circadian rhythms: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Fatigue associated with cancer and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Changing the dosing schedule minimizes the disruptive effects of interferon on clock function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Time dependency of hematopoietic growth factor coupled to chronotoxicity of carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Severe pulmonary toxicity in a patient treated with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

Fatigue and cancer: causes, prevalence and treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0748730406298984

21 January 2018

Identifiers

DOI

10.1177/0748730406298984

1 reference

3 May 2018

1 reference

3 May 2018